Evidence map›Paper›PMID 41030379›Full record

ArticleEuropean heart journal. Case reports2025

Cardiac AL amyloidosis in a veteran endurance athlete with pre-existing apical hypertrophic cardiomyopathy: a case report.

Emmanuel Androulakis, Szymon Musiol, Michael Papadakis, Maria Teresa Tome Esteban

Abstract readCase Reports
In one paragraph

Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Emmanuel AndroulakisKings College Hospital NHS Foundation Trust, Cardiac Unit, Denmark Hill, London SE5 9RS, UK.ORCID https://orcid.org/0000-0001-8843-2171
Szymon MusiolRoyal United Hospitals NHS Foundation Trust, Cardiology Department, Combe Park, Bath BA1 3NG, UK.ORCID https://orcid.org/0000-0003-1035-0525
Michael PapadakisSt George's University Hospitals NHS Foundation Trust, Cardiology Clinical Academic Group, Blackshaw Road, London SW17 0QT, UK.ORCID https://orcid.org/0000-0003-0616-2353
Maria Teresa Tome EstebanSt George's University Hospitals NHS Foundation Trust, Cardiology Clinical Academic Group, Blackshaw Road, London SW17 0QT, UK.ORCID https://orcid.org/0000-0002-8962-3524

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with mild phenotypes of chronic cardiomyopathies are often followed up over time, and there is a temptation to assume a change in symptom status or investigation results is due to the original pathology. The possibility of acquired pathology must be considered in these patients. Case summary: We present a case of a middle-aged veteran endurance athlete followed up for a mild phenotype of apical hypertrophic cardiomyopathy originally picked up due to an asymptomatic abnormal electrocardiogram (ECG). He developed subtle symptoms and morphological changes in his investigations (ECG, echocardiography, exercise tolerance test (ETT), and magnetic resonance imaging (MRI)). Due to the previously quiescent phenotype, a diagnosis of coexistent amyloid light-chain (AL) cardiac amyloidosis secondary to IgA lambda multiple myeloma was made. Discussion: This case underscores the importance of paying attention to subtle changes in symptoms and morphology when managing patients with mild phenotypes and athletes, and considering alternative pathology when these occur. Multimodality imaging is essential in the investigation of such patients.

Indexed as

Cardiac amyloidosisCase reportEndurance athleteHypertrophic cardiomyopathyMultimodality imaging

Identifiers

PMID41030379
PMCPMC12477468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.